| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
DiaMedica Therapeutics (NASDAQ:DMAC) is set to give its latest quarterly earnings report on Tuesday, 2025-08-12. Here's what investors need to know before the announcement.
Analysts estimate that DiaMedica Therapeutics will report an earnings per share (EPS) of $-0.19.
DiaMedica Therapeutics bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
The company's EPS missed by $0.00 in the last quarter, leading to a 0.5% increase in the share price on the following day.
Here's a look at DiaMedica Therapeutics's past performance and the resulting price change:
| Quarter | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.18 | -0.17 | -0.15 | -0.16 |
| EPS Actual | -0.18 | -0.18 | -0.15 | -0.13 |
| Price Change % | 1.0% | -13.0% | -3.0% | 3.0% |
Shares of DiaMedica Therapeutics were trading at $4.67 as of August 08. Over the last 52-week period, shares are up 28.49%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
To track all earnings releases for DiaMedica Therapeutics visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: DMAC
